Garry E Menzel Insider Trading $BDTX Black Diamond Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Garry E Menzel.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Garry E Menzel. Garry E Menzel is COO & Executive VP, Finance in Regulus Therapeutics Inc. ($RGLS) and Director in Stoke Therapeutics, Inc. ($STOK) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and President & CEO in TCR2 THERAPEUTICS INC. ($TCRR) and President and CEO in TCR2 THERAPEUTICS INC. ($TCRR).

Garry E Menzel in Black Diamond Therapeutics, Inc.

Trading Symbol: BDTX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Garry E Menzel: Director
Holdings: 51,825 shares
Latest Transaction: Jun 22 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Garry E Menzel in Black Diamond Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, BDTX, RGLS, STOK, TCRR

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 22 2021BDTXBlack Diamond Ther ...Menzel Garry EDirectorOption ExerciseA12.5515,000188,25015,000
Apr 23 2021BDTXBlack Diamond Ther ...Menzel Garry EDirectorOption ExerciseA24.3314,921363,02814,921
Apr 23 2021BDTXBlack Diamond Ther ...Menzel Garry EDirectorOption ExerciseA24.3314,921363,02814,921
Feb 05 2020BDTXBlack Diamond Ther ...Menzel Garry EDirectorOption ExerciseC0.00156,29700
Feb 05 2020BDTXBlack Diamond Ther ...Menzel Garry EDirectorBuyC0.0051,825051,8250 to 51.8 K

Page:   1